Cannon, R. E., Peart, J. C., Hawkins, B. T., Campos, C. R., & Miller, D. S. (2012). Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain. National Academy of Sciences.

Cannon, Ronald E., John C. Peart, Brian T. Hawkins, Christopher R. Campos, và David S. Miller. Targeting Blood-brain Barrier Sphingolipid Signaling Reduces Basal P-glycoprotein Activity and Improves Drug Delivery to the Brain. National Academy of Sciences, 2012.

Cannon, Ronald E., et al. Targeting Blood-brain Barrier Sphingolipid Signaling Reduces Basal P-glycoprotein Activity and Improves Drug Delivery to the Brain. National Academy of Sciences, 2012.